Search Results

You are looking at 151 - 160 of 793 items for :

  • "screening" x
Clear All
Full access

Peter F. Coccia, Jessica Altman, Smita Bhatia, Scott C. Borinstein, Joseph Flynn, Suzanne George, Robert Goldsby, Robert Hayashi, Mary S. Huang, Rebecca H. Johnson, Lynda Kwon Beaupin, Michael P. Link, Kevin C. Oeffinger, Kathleen M. Orr, Alberto S. Pappo, Damon Reed, Holly L. Spraker, Deborah A. Thomas, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Bradley J. Zebrack, Hema Sundar and Dorothy A. Shead

, TP53 (Li-Fraumeni syndrome), or PTEN (Cowden syndrome), or those who have received mantle field irradiation for HL are at an increased risk of developing breast cancer during young adulthood. 1 , 11 Screening for breast cancer may be warranted in

Full access

J. Matt McCrary, David Goldstein, Terry Trinh, Hannah C. Timmins, Tiffany Li, Jasmine Menant, Michael Friedlander, Craig R. Lewis, Mark Hertzberg, Siobhan O’Neill, Tracy King, Annmarie Bosco, Michelle Harrison and Susanna B. Park

measures provides the most comprehensive approach. 11 For clinical use, a recent Delphi survey showed that any CIPN assessment with ≥6 items is unlikely to be feasible. 10 The development of targeted assessments to facilitate clinical screening of

Full access

Azeez Farooki

modulate the risk of osteonecrosis of the jaw and atypical femur fracture (AFF). Screening for Osteoporosis to Reduce the Risk of Fracture Characterized by low bone mass and structural deterioration of the microarchitecture of bone tissue

Full access

Archna Sarwal and Andrew J. Roth

– 147 . ( Most recent version available at ). 9 Roth AJ Kornblith AB Batel-Copel L . Rapid screening for psychologic distress in men with prostate cancer: A pilot study . Cancer 1998 ; 82 : 1904 – 1908 . 10

Full access

Philip E. Lammers, Christine M. Lovly and Leora Horn

showed the likely presence of a germline EGFR T790M mutation, which has been previously reported. 21 - 23 With the expansion of mutational screening to a wider audience and the high sensitivity of the testing, a larger number of patients will be found

Full access

Jennifer B. Ogilvie and Electron Kebebew

Grauer A . Multiple endocrine neoplasia type 2: clinical features and screening . Endocrinol Metab Clin North Am 1994 ; 23 : 137 – 156 . 14. Pomares FJ Canas R Rodriguez JM . Differences between sporadic and multiple endocrine Neoplasia

Full access

Jimmie C. Holland, Brian J. Kelly and Mark I. Weinberger

for the management of distress, recommending that patients be first screened for distress with a short, initial, rapid screening question, followed by a second phase during which the doctor or nurse asks about specific problems. This process should be

Full access

Bhumsuk Keam, Jeong-Hoon Lee, Seock-Ah Im and Jung-Hwan Yoon

immunosuppressive therapy. 24 , 27 However, the Korean guidelines do not recommend routine screening for anti-HBc antibodies 25 because most HBV infections result from vertical transmission in Korea. 81 The European guidelines 24 recommend that patients who are

Full access

Tanner M. Johanns, Cole J. Ferguson, Patrick M. Grierson, Sonika Dahiya and George Ansstas

considerations: (1) routine screening for the presence of BRAF point mutations in adult HGGs should be part of the initial molecular characterization; (2) treatment with targeted therapy in newly diagnosed, BRAF -mutated HGGs is a safe and effective approach

Full access

Paul G. Richardson, Jacob P. Laubach, Robert L. Schlossman, Constantine Mitsiades and Kenneth Anderson

screening, patients should be asked to assess their level of fatigue during the previous 7-day period, using a predefined scale. A comprehensive primary asthenia examination is recommended for all patients reporting moderate to severe fatigue. No